<img src="https://secure.intelligence52.com/795232.png" style="display:none;">

Blog

Longitudinal Observational Data in Paediatric Disease Registries

By Statistical Consultancy Team
September 11, 2026
How longitudinal observational data from registries can inform growth, maturation and safety analyses, with key risks around bias and follow-up.
Learn more

Tipping Point Analysis in Clinical Trials

By Statistical Consultancy Team
September 9, 2026
Understand tipping point analysis in clinical trials, including MAR, MNAR, delta shifts, endpoint types, and key limitations.
Learn more

Clinical Trial Planning and Design: What to Plan Before Execution

By Statistical Consultancy Team
September 4, 2026
See how clinical trial planning and design connects the research question with population, endpoints, comparator choice, analysis and feasibility.
Learn more

What is a Clinical Development Plan (CDP) and What Should It Include?

By Statistical Consultancy Team
September 2, 2026
Understand how a clinical development plan supports cross-functional decisions, regulatory interactions, risk planning and trial delivery.
Learn more

Clinical Trial Trends Shaping Modern Drug Development

By Commercial Team
August 28, 2026
Explore clinical trial trends affecting the future of clinical trials, including DCTs, PROs, advanced therapies and outsourcing.
Learn more

The Analysis of Direct and Indirect Pathways in Observational Studies

By Statistical Consultancy Team
August 26, 2026
Understand direct vs indirect pathways in an AS observational study, including direct effect, indirect effect, binary mediators, and limitations.
Learn more

The Role of Data Monitoring Committees (DMC) in Clinical Trials

By Statistical Consultancy Team
August 21, 2026
A practical data monitoring committee overview covering DMC responsibilities, confidentiality, interim analysis and independent statistical support.
Learn more

Group Sequential Designs in Clinical Trials: A Practical Guide

By Statistical Consultancy Team
August 14, 2026
Understand group sequential designs, stopping boundaries, alpha spending and when interim looks are useful in clinical trials.
Learn more

What is Audit Trail Review in Clinical Trials?

By Clinical Data Management Team
August 11, 2026
See how audit trail review supports clinical trial oversight through proportionate scope, clear ownership, contextual review, and documented findings.
Learn more

How an SDTM Mapping Automation Tool Supports Data Standardisation

By Clinical Programming Team
August 7, 2026
Understand where an SDTM mapping automation tool can help, where human review is needed, and why metadata quality matters.
Learn more

AI in Clinical Trial Design for Study Teams and Sponsors

By Statistical Consultancy Team
July 30, 2026
How AI in clinical trial design can support feasibility, recruitment, data review, and governance when used with clear human oversight.
Learn more

Respiratory Clinical Trials Across Key Indications

By Statistical Consultancy Team
July 27, 2026
Understand how respiratory clinical trials differ across asthma, COPD, IPF, Long COVID, infections, and other respiratory diseases.
Learn more

Subscribe to the Blog